NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-281-2009-0-US-01 Diagnosis and Treatment of Cancer Through NUAK2 Assessment and Modulation US 61/321,136 Abandoned
NINDS E-309-2009-1-EP-05 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems EP National Stage 10759504.3 Issued
NINDS E-309-2009-1-CA-04 Microstructures For Magnetic Resonance Imaging CA National Stage 2757533 Issued
NINDS E-309-2009-1-US-02 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems US ORD 12/753,689 9084819 Issued PDF
NINDS E-309-2009-1-AU-03 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems AU National Stage 2010232430 Issued
NCI E-113-2003-0-US-07 Target Activated Microtransfer US DIV 12/753,566 8597715 Issued PDF
NINDS E-309-2009-1-PCT-01 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems PCT PCT COMB PCT/US10/029839 Expired
NCI E-058-2009-0-US-02 Antibodies That Bind GaLNAc1-3Gal, Pharmaceutical Compositions and Methods Of Using Same US ORD 12/752,331 8957188 Issued PDF
NCI E-317-2004-1-US-04 Metal Chelators And Methods of Their Use US DIV 12/752,419 8454936 Abandoned PDF
NCI E-099-1996-0-US-47 AGONIST AND ANTAGONIST PEPTIDES OF CARCINOEMBRYONIC ANTIGEN (CEA) US CON 12/752,768 Abandoned
NIDCR E-018-2009-1-AU-02 Differentially Expressed MicroRNAs As Biomarkers For The Diagnosis And Treatment Of Sjogren's Syndrome AU National Stage 2010234806 Abandoned
NIDCR E-018-2009-1-PCT-01 Differentially Expressed MicroRNAs as Biomarkers for the Diagnosis and Treatment of Sjogren's PCT PCT COMB PCT/US2010/029307 Expired
NIDCR E-018-2009-1-EP-04 Differentially Expressed MicroRNAs As Biomarkers For The Diagnosis And Treatment Of Sjogren's Syndrome EP National Stage 10762205.2 Abandoned
NIDCR E-018-2009-1-JP-05 Differentially Expressed MicroRNAs As Biomarkers For The Diagnosis And Treatment Of Sjogrens Syndrome JP National Stage 2012-503638 Abandoned
NIDCR E-018-2009-1-CA-03 Differentially Expressed MicroRNAs As Biomarkers For The Diagnosis And Treatment Of Sjogren's Syndrome CA National Stage 2754412 Abandoned
NICHD E-247-2009-1-US-01 Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes US 61/319,285 Abandoned
NICHD E-042-2013-0-US-01 Injectable Dendrimer Hydrogel Nanoparticles US 61/319,289 Abandoned
NHGRI E-094-2010-0-US-01 Use Of Adenosine Agonists To Prevent Arterial Vascular Calcification US 61/319,336 Abandoned
NCI E-063-2003-0-US-05 Rapamycin-Resistant T Cells and Therapeutics Uses Thereof US DIV 12/750,374 8075921 Expired PDF
NIA E-241-2008-0-PCT-02 Posiphen And Analogues Suppress Production Of Alpha-synculein Protein PCT PCT PCT/US10/029056 Expired
NHLBI E-254-2003-3-US-20 Use of Nitrite Salts For The Treatment Of Cardiovascular Conditions US CON 12/748,184 8927030 Issued PDF
NINDS E-187-2007-0-US-03 Isoindoline Compounds For The Treatment Of Spinal Muscular Atrophy (SMA) And Other Uses US National Stage 12/680,285 Abandoned
NCI E-051-2010-0-US-01 HUMAN POLYOMAVIRUS 6 (HPyV6) AND HUMAN POLYOMAVIRUS 7 (HPyV7) US 61/318,080 Abandoned
NCI E-091-2009-0-CA-04 Anti-Mesothelin Antibodies CA National Stage 2756393 Issued
NCI E-091-2009-0-AU-03 Anti-Mesothelin Antibodies AU National Stage 2010230063 Issued
NCI E-091-2009-0-US-06 ANTI-MESOTHELIN ANTIBODIES US National Stage 13/259,138 8460660 Issued PDF
NCI E-091-2009-0-PCT-02 Anti-Mesothelin Antibodies PCT PCT PCT/US10/28336 Expired
NCI E-091-2009-0-EP-05 Anti-Mesothelin Antibodies EP National Stage 10722212.7 Abandoned
NCI E-019-2010-0-US-01 Novel Nitroxyl (HNO) Prodrugs And Biomedical Applications Thereof US 61/315,604 Abandoned
NCATS E-252-2009-1-US-01 Discovery Of Potent And Selective Inhibitors Of 15-1 Human Lipoxygenase US 61/315,788 Abandoned
NIDDK E-125-2010-0-US-01 Nicotinic Acetylcholine Receptor Agonists US 61/315,674 Abandoned
NIAID E-148-2009-2-US-02 Use Of Ixolaris, A Tissue Factor (anticoagulant) Inhibitor, For The Treatment Of Cancer US National Stage 13/257,455 8772238 Issued PDF
NIAID E-148-2009-2-PCT-01 Use Of Ixolaris, A Tissue Factor (anticoagulant) Inhibitor, For The Treatment Of Cancer PCT PCT COMB PCT/US2010/027797 Expired
NIDDK E-109-2009-0-PCT-02 Inhibitors of Viral Integrase and Methods of Use PCT PCT PCT/US2010/027870 Expired
NIDDK E-109-2009-0-EP-05 Inhibitors of Viral Integrase and Methods of Use EP National Stage 10754135.1 Abandoned
NCI E-046-2004-0-EP-13 Mutated anti-CD22 Anitbodies and Immunoconjugates EP DIV 10156976.2 Abandoned
NIDDK E-109-2009-0-CA-04 Inhibitors of Viral Integrase and Methods of Use CA National Stage 2755866 Abandoned
NIDDK E-109-2009-0-CN-10 Inhibitors of Viral Integrase and Methods of Use CN National Stage 201080012573.6 Abandoned
NIDDK E-109-2009-0-JP-06 Inhibitors of Viral Integrase and Methods of Use JP National Stage 2012500974 Abandoned
NIDDK E-109-2009-0-AU-03 Inhibitors of Viral Integrase and Methods of Use AU National Stage 2010226541 Abandoned
NHLBI E-028-2008-0-US-03 Methods Of Treatment For Hemolysis US National Stage 12/678,539 8980871 Issued PDF
NCI E-254-1999-0-US-05 New Tumor Suppressor Gene, p47ING3 US DIV 12/724,305 8067563 Abandoned PDF
NIDDK E-049-2010-1-US-01 (N)-Methanocarba Adenosine Derivatives And Their Dendrimer Conjugates As A3 Receptor Agonists US 61/313,961 Abandoned
NCI E-034-2010-0-US-01 A New Type of GlycolipId Antigen Stimulating NKT Cells to Induce Anti-Tumor Immunity US 61/313,508 Abandoned
NCI E-048-2010-0-US-01 Improved Pepper Spray For Repellency And Incapacitation Of People And Animals US 61/340,063 Abandoned
NCI E-003-2010-0-US-01 Modified POTE Peplide Vaccine Againsl Cancer Of The Prostate, Colon, Lung, Breast, Ovary And Pancreas US 61/313,559 Abandoned
NCI E-082-2004-2-AU-08 Methods of Preventing or Treating T Cell Malignancies by Adminstering CD2 Antagonists AU DIV 2010200956 Abandoned
NCATS E-286-2011-0-US-01 Compounds As RORgammat Modulators And Uses Thereof US 61/339,996 Abandoned
NHLBI E-057-2010-0-US-01 RELEASIBLE SNAP-TAG LIGANDS AND METHODS OF MAKING AND
USING SAME 		US 61/312,814 Abandoned
NCATS E-235-2010-0-US-01 HETEROCYCLIC COMPOUNDS AS RORyt MODULATORS AND USES THEREOF US 61/339,974 Abandoned